127 related articles for article (PubMed ID: 24859779)
1. Yellow wine polyphenolic compounds inhibit matrix metalloproteinase-2, -9 expression and improve atherosclerotic plaque in LDL-receptor-knockout mice.
Zhai X; Chi J; Tang W; Ji Z; Zhao F; Jiang C; Lv H; Guo H
J Pharmacol Sci; 2014; 125(2):132-41. PubMed ID: 24859779
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
[TBL] [Abstract][Full Text] [Related]
3. Chinese yellow wine and red wine inhibit matrix metalloproteinase-2 and improve atherosclerotic plaque in LDL receptor knockout mice.
Guo H; Liu L; Shi Y; Sun A; Xu F; Chi J; Huang D
Cardiovasc Ther; 2010 Jun; 28(3):161-8. PubMed ID: 20370796
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
[TBL] [Abstract][Full Text] [Related]
5. Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment?
Marzoll A; Melchior-Becker A; Cipollone F; Fischer JW
J Cell Mol Med; 2011 Feb; 15(2):232-43. PubMed ID: 20015203
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin inhibits TIMP-2 and promotes myocardial angiogenesis.
Siddiqui AJ; Gustafsson T; Sylven C; Crisby M
Pharmacology; 2014; 93(3-4):178-84. PubMed ID: 24854110
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis.
Chen J; Li D; Schaefer RF; Mehta JL
J Cardiovasc Pharmacol; 2004 Oct; 44(4):446-52. PubMed ID: 15454852
[TBL] [Abstract][Full Text] [Related]
8. Effects of rosuvastatin on the production and activation of matrix metalloproteinase-2 and migration of cultured rat vascular smooth muscle cells induced by homocysteine.
Shi YF; Chi JF; Tang WL; Xu FK; Liu LB; Ji Z; Lv HT; Guo HY
J Zhejiang Univ Sci B; 2013 Aug; 14(8):696-704. PubMed ID: 23897788
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
Tousoulis D; Andreou I; Tentolouris C; Antoniades C; Papageorgiou N; Gounari P; Kotrogiannis I; Miliou A; Charakida M; Trikas A; Stefanadis C
Int J Cardiol; 2010 Dec; 145(3):438-43. PubMed ID: 19539384
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
Verreth W; De Keyzer D; Davey PC; Geeraert B; Mertens A; Herregods MC; Smith G; Desjardins F; Balligand JL; Holvoet P
Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients.
Cevik C; Nugent K; Meyerrose G; Otahbachi M; Izgi C; Lyte M; Fish RD
Tex Heart Inst J; 2011; 38(3):229-33. PubMed ID: 21720458
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injury.
Schäfer K; Kaiser K; Konstantinides S
Thromb Haemost; 2005 Jan; 93(1):145-52. PubMed ID: 15630505
[TBL] [Abstract][Full Text] [Related]
13. Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis.
Grönros J; Wikström J; Brandt-Eliasson U; Forsberg GB; Behrendt M; Hansson GI; Gan LM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2046-53. PubMed ID: 18790840
[TBL] [Abstract][Full Text] [Related]
14. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice.
Guo H; Lv H; Tang W; Chi J; Liu L; Xu F; Ji Z; Zhai X; Peng F
Cardiovasc Drugs Ther; 2012 Oct; 26(5):375-82. PubMed ID: 22918601
[TBL] [Abstract][Full Text] [Related]
16. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice.
Moustardas P; Kadoglou NP; Katsimpoulas M; Kapelouzou A; Kostomitsopoulos N; Karayannacos PE; Kostakis A; Liapis CD
PLoS One; 2014; 9(9):e108240. PubMed ID: 25264981
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.
Gianella A; Nobili E; Abbate M; Zoja C; Gelosa P; Mussoni L; Bellosta S; Canavesi M; Rottoli D; Guerrini U; Brioschi M; Banfi C; Tremoli E; Remuzzi G; Sironi L
Am J Pathol; 2007 Apr; 170(4):1165-77. PubMed ID: 17392157
[TBL] [Abstract][Full Text] [Related]
18. Anti-atherogenic and anti-angiogenic activities of polyphenols from propolis.
Daleprane JB; Freitas Vda S; Pacheco A; Rudnicki M; Faine LA; Dörr FA; Ikegaki M; Salazar LA; Ong TP; Abdalla DS
J Nutr Biochem; 2012 Jun; 23(6):557-66. PubMed ID: 21764281
[TBL] [Abstract][Full Text] [Related]
19. Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂.
Rizos CV; Liberopoulos EN; Tellis CC; Florentin M; Elisaf MS; Tselepis AD
Metab Syndr Relat Disord; 2011 Jun; 9(3):217-23. PubMed ID: 21352079
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent effect of rosuvastatin in the regulation of metalloproteinase expression.
Sapienza P; Borrelli V; Sterpetti AV; Dinicola S; Tartaglia E; di Marzo L
Ann Vasc Surg; 2011 Aug; 25(6):823-9. PubMed ID: 21620672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
